SB3688 - 104th General Assembly
| ||||||||||||||||||||||||||
| ||||||||||||||||||||||||||
| ||||||||||||||||||||||||||
| 1 | AN ACT concerning regulation. | |||||||||||||||||||||||||
| 2 | Be it enacted by the People of the State of Illinois, | |||||||||||||||||||||||||
| 3 | represented in the General Assembly: | |||||||||||||||||||||||||
| 4 | Section 5. The Illinois Insurance Code is amended by | |||||||||||||||||||||||||
| 5 | adding Section 356z.88 as follows: | |||||||||||||||||||||||||
| 6 | (215 ILCS 5/356z.88 new) | |||||||||||||||||||||||||
| 7 | Sec. 356z.88. Menopause therapy utilization management | |||||||||||||||||||||||||
| 8 | protections. | |||||||||||||||||||||||||
| 9 | (a) In this Section: | |||||||||||||||||||||||||
| 10 | "Guideline-supported" means consistent with clinical | |||||||||||||||||||||||||
| 11 | practice guidelines or consensus statements issued by | |||||||||||||||||||||||||
| 12 | nationally recognized medical organizations. | |||||||||||||||||||||||||
| 13 | "Menopause therapy" means any hormonal or nonhormonal | |||||||||||||||||||||||||
| 14 | therapy approved by the United States Food and Drug | |||||||||||||||||||||||||
| 15 | Administration for the treatment of perimenopausal or | |||||||||||||||||||||||||
| 16 | menopausal symptoms. | |||||||||||||||||||||||||
| 17 | "Qualified clinician" means a physician licensed under | |||||||||||||||||||||||||
| 18 | the Medical Practice Act of 1987, an advanced practice | |||||||||||||||||||||||||
| 19 | registered nurse licensed under the Nurse Practice Act, or | |||||||||||||||||||||||||
| 20 | a physician assistant licensed under the Physician | |||||||||||||||||||||||||
| 21 | Assistant Practice Act of 1987 acting within the scope of | |||||||||||||||||||||||||
| 22 | the clinician's license. | |||||||||||||||||||||||||
| 23 | (b) A group or individual policy of accident and health | |||||||||||||||||||||||||
| |||||||
| |||||||
| 1 | insurance issued or renewed in this State shall not impose | ||||||
| 2 | prior authorization or step therapy requirements on menopause | ||||||
| 3 | therapy when all of the following conditions are met: | ||||||
| 4 | (1) the therapy is approved by the United States Food | ||||||
| 5 | and Drug Administration; | ||||||
| 6 | (2) the therapy is guideline-supported; and | ||||||
| 7 | (3) the therapy is prescribed by a qualified clinician | ||||||
| 8 | for the treatment of perimenopausal or menopausal | ||||||
| 9 | symptoms. | ||||||
| 10 | (c) Nothing in this Section shall be construed to | ||||||
| 11 | prohibit: | ||||||
| 12 | (1) formulary tiering if access to guideline-supported | ||||||
| 13 | menopause therapy is not unreasonably restricted; or | ||||||
| 14 | (2) utilization management based on documented | ||||||
| 15 | patient-specific safety concerns, contraindications, or | ||||||
| 16 | drug interactions. | ||||||
| 17 | (d) The Department shall enforce this Section and may | ||||||
| 18 | adopt rules necessary to implement this Section. | ||||||
| 19 | Section 10. The Medical Practice Act of 1987 is amended by | ||||||
| 20 | changing Section 20 as follows: | ||||||
| 21 | (225 ILCS 60/20) (from Ch. 111, par. 4400-20) | ||||||
| 22 | (Section scheduled to be repealed on January 1, 2027) | ||||||
| 23 | Sec. 20. Continuing education. | ||||||
| 24 | (a) The Department shall promulgate rules of continuing | ||||||
| |||||||
| |||||||
| 1 | education for persons licensed under this Act that require an | ||||||
| 2 | average of 50 hours of continuing education per license year. | ||||||
| 3 | These rules shall be consistent with requirements of relevant | ||||||
| 4 | professional associations, specialty societies, or boards. The | ||||||
| 5 | rules shall also address variances in part or in whole for good | ||||||
| 6 | cause, including, but not limited to, temporary illness or | ||||||
| 7 | hardship. In establishing these rules, the Department shall | ||||||
| 8 | consider educational requirements for medical staffs, | ||||||
| 9 | requirements for specialty society board certification or for | ||||||
| 10 | continuing education requirements as a condition of membership | ||||||
| 11 | in societies representing the 2 categories of licensee under | ||||||
| 12 | this Act. These rules shall assure that licensees are given | ||||||
| 13 | the opportunity to participate in those programs sponsored by | ||||||
| 14 | or through their professional associations or hospitals which | ||||||
| 15 | are relevant to their practice. Each licensee is responsible | ||||||
| 16 | for maintaining records of completion of continuing education | ||||||
| 17 | and shall be prepared to produce the records when requested by | ||||||
| 18 | the Department. | ||||||
| 19 | (b) The Department shall require physicians licensed under | ||||||
| 20 | this Act to complete continuing medical education on | ||||||
| 21 | perimenopause and menopause recognition and management. This | ||||||
| 22 | education shall: | ||||||
| 23 | (1) not exceed 2 hours per renewal cycle; | ||||||
| 24 | (2) count toward existing continuing medical education | ||||||
| 25 | requirements; and | ||||||
| 26 | (3) not increase the total number of continuing | ||||||
| |||||||
| |||||||
| 1 | education hours required for license renewal. | ||||||
| 2 | The continuing education required under this subsection | ||||||
| 3 | shall include instruction in: | ||||||
| 4 | (i) common and atypical symptom patterns of | ||||||
| 5 | perimenopause and menopause and appropriate differential | ||||||
| 6 | diagnosis; | ||||||
| 7 | (ii) appropriate and limited use of laboratory | ||||||
| 8 | testing, including when testing is not clinically | ||||||
| 9 | indicated; | ||||||
| 10 | (iii) evidence-based treatment options and referral | ||||||
| 11 | standards; and | ||||||
| 12 | (iv) mental health considerations and culturally | ||||||
| 13 | competent care related to perimenopause and menopause. | ||||||
| 14 | The Department shall approve qualifying continuing | ||||||
| 15 | education courses and may adopt rules necessary to implement | ||||||
| 16 | this subsection. | ||||||
| 17 | (Source: P.A. 97-622, eff. 11-23-11.) | ||||||
| 18 | Section 15. The Nurse Practice Act is amended by changing | ||||||
| 19 | Section 65-60 as follows: | ||||||
| 20 | (225 ILCS 65/65-60) (was 225 ILCS 65/15-45) | ||||||
| 21 | (Section scheduled to be repealed on January 1, 2028) | ||||||
| 22 | Sec. 65-60. Continuing education. | ||||||
| 23 | (a) The Department shall adopt rules of continuing | ||||||
| 24 | education for persons licensed under this Article as advanced | ||||||
| |||||||
| |||||||
| 1 | practice registered nurses that require 80 hours of continuing | ||||||
| 2 | education per 2-year license renewal cycle. Completion of the | ||||||
| 3 | 80 hours of continuing education shall be deemed to satisfy | ||||||
| 4 | the continuing education requirements for renewal of a | ||||||
| 5 | registered professional nurse license as required by this Act. | ||||||
| 6 | (b) The 80 hours of continuing education required under | ||||||
| 7 | this Section shall be completed as follows: | ||||||
| 8 | (1) A minimum of 50 hours of the continuing education | ||||||
| 9 | shall be obtained in continuing education programs as | ||||||
| 10 | determined by rule that shall include no less than 20 | ||||||
| 11 | hours of pharmacotherapeutics, including 10 hours of | ||||||
| 12 | opioid prescribing or substance abuse education. | ||||||
| 13 | Continuing education programs may be conducted or endorsed | ||||||
| 14 | by educational institutions, hospitals, specialist | ||||||
| 15 | associations, facilities, or other organizations approved | ||||||
| 16 | to offer continuing education under this Act or rules and | ||||||
| 17 | shall be in the advanced practice registered nurse's | ||||||
| 18 | specialty. | ||||||
| 19 | (2) A maximum of 30 hours of credit may be obtained by | ||||||
| 20 | presentations in the advanced practice registered nurse's | ||||||
| 21 | clinical specialty, evidence-based practice, or quality | ||||||
| 22 | improvement projects, publications, research projects, or | ||||||
| 23 | preceptor hours as determined by rule. | ||||||
| 24 | (c) The Department shall require advanced practice | ||||||
| 25 | registered nurses to complete continuing education on | ||||||
| 26 | perimenopause and menopause recognition and management. This | ||||||
| |||||||
| |||||||
| 1 | education shall: | ||||||
| 2 | (1) not exceed 2 hours per renewal cycle; | ||||||
| 3 | (2) count toward existing continuing education | ||||||
| 4 | requirements; and | ||||||
| 5 | (3) not increase the total number of continuing | ||||||
| 6 | education hours required for license renewal. | ||||||
| 7 | The continuing education required under this subsection | ||||||
| 8 | shall include instruction in: | ||||||
| 9 | (i) common and atypical symptom patterns of | ||||||
| 10 | perimenopause and menopause and appropriate differential | ||||||
| 11 | diagnosis; | ||||||
| 12 | (ii) appropriate and limited use of laboratory | ||||||
| 13 | testing, including when testing is not clinically | ||||||
| 14 | indicated; | ||||||
| 15 | (iii) evidence-based treatment options and referral | ||||||
| 16 | standards; and | ||||||
| 17 | (iv) mental health considerations and culturally | ||||||
| 18 | competent care related to perimenopause and menopause. | ||||||
| 19 | The Department shall approve qualifying continuing | ||||||
| 20 | education courses and may adopt rules necessary to implement | ||||||
| 21 | this subsection. | ||||||
| 22 | (c) The rules adopted regarding continuing education | ||||||
| 23 | shall be consistent to the extent possible with requirements | ||||||
| 24 | of relevant national certifying bodies or State or national | ||||||
| 25 | professional associations. | ||||||
| 26 | The rules shall not be inconsistent with requirements of | ||||||
| |||||||
| |||||||
| 1 | relevant national certifying bodies or State or national | ||||||
| 2 | professional associations. The rules shall also address | ||||||
| 3 | variances in part or in whole for good cause, including but not | ||||||
| 4 | limited to illness or hardship. The continuing education rules | ||||||
| 5 | shall assure that licensees are given the opportunity to | ||||||
| 6 | participate in programs sponsored by or through their State or | ||||||
| 7 | national professional associations, hospitals, or other | ||||||
| 8 | providers of continuing education. Each licensee is | ||||||
| 9 | responsible for maintaining records of completion of | ||||||
| 10 | continuing education and shall be prepared to produce the | ||||||
| 11 | records when requested by the Department. | ||||||
| 12 | (Source: P.A. 100-513, eff. 1-1-18.) | ||||||
| 13 | Section 20. The Physician Assistant Practice Act of 1987 | ||||||
| 14 | is amended by changing Section 11.5 as follows: | ||||||
| 15 | (225 ILCS 95/11.5) | ||||||
| 16 | (Section scheduled to be repealed on January 1, 2028) | ||||||
| 17 | Sec. 11.5. Continuing education. | ||||||
| 18 | (a) The Department shall adopt rules for continuing | ||||||
| 19 | education for persons licensed under this Act that require 50 | ||||||
| 20 | hours of continuing education per 2-year license renewal | ||||||
| 21 | cycle. Completion of the 50 hours of continuing education | ||||||
| 22 | shall be deemed to satisfy the continuing education | ||||||
| 23 | requirements for renewal of a physician assistant license as | ||||||
| 24 | required by this Act. The rules shall not be inconsistent with | ||||||
| |||||||
| |||||||
| 1 | requirements of relevant national certifying bodies or State | ||||||
| 2 | or national professional associations. The rules shall also | ||||||
| 3 | address variances in part or in whole for good cause, | ||||||
| 4 | including, but not limited to, illness or hardship. The | ||||||
| 5 | continuing education rules shall ensure that licensees are | ||||||
| 6 | given the opportunity to participate in programs sponsored by | ||||||
| 7 | or through their State or national professional associations, | ||||||
| 8 | hospitals, or other providers of continuing education. Each | ||||||
| 9 | licensee is responsible for maintaining records of completion | ||||||
| 10 | of continuing education and shall be prepared to produce the | ||||||
| 11 | records when requested by the Department. | ||||||
| 12 | (b) The Department shall require physician assistants to | ||||||
| 13 | complete continuing education on perimenopause and menopause | ||||||
| 14 | recognition and management. This education shall: | ||||||
| 15 | (1) not exceed 2 hours per renewal cycle; | ||||||
| 16 | (2) count toward existing continuing education | ||||||
| 17 | requirements; and | ||||||
| 18 | (3) not increase the total number of continuing | ||||||
| 19 | education hours required for license renewal. | ||||||
| 20 | The continuing education required under this Section shall | ||||||
| 21 | include instruction in: | ||||||
| 22 | (i) common and atypical symptom patterns of | ||||||
| 23 | perimenopause and menopause and appropriate differential | ||||||
| 24 | diagnosis; | ||||||
| 25 | (ii) appropriate and limited use of laboratory | ||||||
| 26 | testing, including when testing is not clinically | ||||||
| |||||||
| |||||||
| 1 | indicated; | ||||||
| 2 | (iii) evidence-based treatment options and referral | ||||||
| 3 | standards; and | ||||||
| 4 | (iv) mental health considerations and culturally | ||||||
| 5 | competent care related to perimenopause and menopause. | ||||||
| 6 | The Department shall approve qualifying continuing | ||||||
| 7 | education courses and may adopt rules necessary to implement | ||||||
| 8 | this subsection. | ||||||
| 9 | (Source: P.A. 100-453, eff. 8-25-17.) | ||||||
| 10 | Section 99. Effective date. This Act takes effect January | ||||||
| 11 | 1, 2027. | ||||||
